Literature DB >> 17090730

Vorinostat approved for rare lymphoma.

Cheryl A Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17090730     DOI： 10.2146/news060020

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  4 in total

Review 1.  The MOZ histone acetyltransferase in epigenetic signaling and disease.

Authors:  Samuel Carlson; Karen C Glass
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

2.  Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition.

Authors:  Dahea You; Jason R Richardson; Lauren M Aleksunes
Journal:  Drug Metab Dispos       Date:  2020-03-19       Impact factor: 3.922

3.  Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma.

Authors:  Tianjiao Lyu; Nan Jia; Jieyu Wang; Xiaohui Yan; Yinhua Yu; Zhen Lu; Robert C Bast; Keqin Hua; Weiwei Feng
Journal:  Epigenetics       Date:  2013-10-17       Impact factor: 4.528

4.  Chidamide increases the sensitivity of Non-small Cell Lung Cancer to Crizotinib by decreasing c-MET mRNA methylation.

Authors:  Nan Ding; Abin You; Wei Tian; Liankun Gu; Dajun Deng
Journal:  Int J Biol Sci       Date:  2020-07-19       Impact factor: 6.580
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.